COMPUTATIONAL APPROACHES TO UNDERSTAND THE INTERACTION OF HIV-1 INTEGRASE AND I

理解 HIV-1 整合酶和 I 相互作用的计算方法

• 批准号: 8171776
• 负责人: Zengjian Hu
• 金额: $ 0.11万
• 依托单位: CARNEGIE-MELLON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-08-01 至 2013-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8171776
• 关键词: AIDS therapy; Anti-HIV Agents; Binding; Biological Factors; Catalytic Domain; Cells; Chinese Herbs; Chromosomes; Complement; Complex; Computer Retrieval of Information on Scientific Projects Database; DNA; Drug Design; Enzyme Inhibitor Drugs; Enzyme Inhibitors; Enzymes; Exhibits; Funding; Genome; Grant; HIV; HIV Protease; HIV-1; HIV-1 integrase; Herbal Medicine; Institution; Integrase; Lead; Life Cycle Stages; Methodology; Molecular Models; Research; Research Personnel; Resources; Reverse Transcriptase Inhibitors; Scutellaria baicalensis; Source; Structure; Techniques; Therapeutic Uses; United States National Institutes of Health; Work; baicalein; baicalin; base; design; drug candidate; inhibitor/antagonist; molecular modeling

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. An essential step in the life cycle of human immunodeficiency virus type 1 (HIV-1) is integration of the double-stranded retroviral DNA into the genome of the host cell. HIV- 1 integrase, the enzyme that insertors, ts the vital DNA into the host chromosome, is an attractive and rational target for anti-AIDS drug design because it is essential for HIV replication and there are no known counterparts in the host cell. Inhibitors of this enzyme have the great potential to complement the therapeutic use of HIV protease and reverse transcriptase inhibitors. Natural products have provided a source of new drug candidates for anti-AIDS therapy. The number of compounds exhibiting anti-HIV activity and isolated from natural sources has increase steadily. Baicalein and baicalin, identified components of a Chinese herbal medicine Scutellaria baicalensis Georgi, have been shown to inhibit infectivity and replication of HIV. They are therefore promising lead compounds for developing new anti-AIDS drugs. To understand how the inhibitors work and therefore design more potent and specific inhibitors, we have used molecular modeling techniques to investigate the binding modes of these inhibitors. Computational binding studies of these inhibitors, based on the crystal structure of the HIV-1 integrase catalytic domain, will be performed to study the complex structure using QM/MM methodology.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 中心，不一定是研究者的机构。 1 型人类免疫缺陷病毒 (HIV-1) 生命周期中的一个重要步骤是 将双链逆转录病毒DNA整合到宿主细胞的基因组中。艾滋病病毒- 1 整合酶，将重要 DNA 插入宿主染色体的酶，是一种 抗艾滋病药物设计的有吸引力且合理的目标，因为它对于艾滋病毒至关重要 复制并且在宿主细胞中没有已知的对应物。这种抑制剂 酶具有补充 HIV 蛋白酶治疗用途的巨大潜力 和逆转录酶抑制剂。天然产品提供了新的来源 抗艾滋病治疗的候选药物。表现出抗 HIV 活性的化合物数量 活动和从自然资源中分离出来的物质稳步增加。黄芩素和黄芩甙， 经鉴定，中草药黄芩的成分 已被证明可以抑制 HIV 的感染性和复制。因此他们充满希望 用于开发新的抗艾滋病药物的先导化合物。了解抑制剂如何 工作，因此设计更有效和特异性的抑制剂，我们使用了分子 建模技术来研究这些抑制剂的结合模式。 基于这些抑制剂的晶体结构的计算结合研究 HIV-1整合酶催化结构域，将用于研究复杂结构 QM/MM 方法。